Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.06.2018 | Case report

Immunosuppressants

Infections: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

A male patient [exact age at the time of reaction onset not stated] developed severe infections following immunosuppression with unspecified steroids, azathioprine, infliximab, adalimumab, methotrexate and vedolizumab for inflammatory bowel disease [route, dosage, duration of treatments to reaction onset and outcome not stated]. …
Fußnoten
1
Mesalazine [mesalamine] is not a immunosuppressant. Therefore, it is not considered as suspect.
 
Literatur
Metadaten
Titel
Immunosuppressants
Infections: case report
Publikationsdatum
01.06.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-48274-7

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Antineoplastics

Case report

Tocilizumab

Case report

Insulin

Case report

Omalizumab